Catalyst Pharmaceuticals Balance Sheet (2010-2026) | CPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	135.29M	154.84M	171.44M	178.37M	210.91M	256.06M	298.39M	148.25M	178.79M	120.97M	137.64M	310.41M	375.69M	442.33M	517.55M	580.66M	652.80M	689.89M	709.17M	755.86M
Short-term Investments (Quarter)	19.98M	19.96M	19.82M	19.42M	9.88M
Cash & Current Investments (Quarter)	155.28M	174.79M	191.27M	197.80M	220.79M	256.06M	298.39M	148.25M	178.79M	120.97M	137.64M	310.41M	375.69M	442.33M	517.55M	580.66M	652.80M	689.89M	709.17M	755.86M
Receivables - Net (Quarter)	6.29M	6.62M	6.62M	10.55M	9.59M	9.34M	10.44M	33.40M	42.80M	48.05M	53.51M	60.49M	57.17M	58.27M	65.48M	71.27M	65.86M	106.41M	126.48M	130.83M
Receivables - Other (Quarter)
Receivables (Quarter)	6.29M	6.62M	6.62M	10.55M	9.59M	9.34M	10.44M	33.40M	42.80M	48.05M	53.51M	60.49M	57.17M	58.27M	65.48M	71.27M	65.86M	106.41M	126.48M	130.83M
Raw Materials (Quarter)											1.91M		5.60M	6.95M	6.52M	7.43M	5.19M	12.14M	17.14M	16.88M
Work In Process (Quarter)											4.57M		4.02M	3.83M	3.44M	4.22M	5.34M	4.60M	3.87M	2.77M
Finished Goods (Quarter)											9.16M		8.39M	9.24M	9.58M	8.12M	8.12M	11.29M	16.16M	15.28M
Inventory (Quarter)	7.10M	6.95M	7.87M	7.83M	7.85M	7.13M	6.80M	10.33M	10.75M	9.04M	15.64M	19.95M	18.01M	20.02M	19.54M	19.78M	18.65M	28.03M	37.17M	34.93M
Prepaid Assets (Quarter)	7.64M	4.43M	4.35M	5.02M	4.33M	3.78M	5.17M	6.93M	8.63M	13.96M	1.33M	13.74M	23.55M	0.51M	0.51M	0.45M	1.06M	0.54M	5.92M	1.13M
Current Assets (Quarter)	176.31M	192.79M	210.11M	221.19M	242.56M	276.31M	320.81M	198.91M	240.97M	192.02M	219.33M	404.60M	474.43M	539.00M	623.61M	685.72M	758.74M	852.45M	894.03M	940.39M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.91M	0.95M	0.96M	0.93M	0.92M	0.88M	0.85M	1.28M	1.20M	1.19M	1.20M	1.31M	1.23M	1.38M	1.35M	1.24M	1.15M	1.08M	1.04M	0.99M
Long-Term Investments (Quarter)										12.90M	16.49M	15.35M	13.08M	14.84M	21.56M	24.21M	21.26M	19.17M	22.54M	27.29M
Intangibles (Quarter)						33.05M	32.47M	184.08M	175.59M	167.11M	194.05M	184.71M	227.71M	227.71M	227.71M	227.71M	227.71M	128.64M	131.67M	121.97M
Goodwill & Intangibles (Quarter)						33.05M	32.47M	184.08M	175.59M	167.11M	194.05M	184.71M	227.71M	227.71M	227.71M	227.71M	227.71M	128.64M	131.67M	121.97M
Long-Term Deferred Tax (Quarter)	28.70M	26.40M	23.70M	21.89M	20.93M	20.03M	18.74M	20.24M	23.49M	37.43M	36.54M	38.28M	39.89M	48.47M	45.98M	48.22M	50.70M	48.26M	52.77M	55.11M
Other Non-Current Assets (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Assets (Quarter)	32.83M	30.45M	27.68M	25.78M	24.75M	56.80M	54.82M	208.32M	202.93M	221.19M	250.78M	242.07M	231.93M	233.01M	227.80M	223.15M	213.18M	199.15M	209.95M	207.22M
Assets (Quarter)	209.13M	223.25M	237.79M	246.97M	267.31M	333.11M	375.63M	407.23M	443.90M	413.21M	470.11M	646.68M	706.36M	772.01M	851.41M	908.87M	971.91M	1,051.60M	1,103.98M	1,147.61M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.92M	2.75M	2.77M	5.14M	2.31M	2.53M	3.98M	3.39M	4.42M	4.60M	14.79M	10.26M	7.12M	11.56M	16.59M	11.20M	5.53M	9.10M	11.20M	7.15M
Payables (Quarter)	2.92M	2.75M	2.77M	5.14M	2.31M	2.53M	3.98M	3.39M	4.42M	4.60M	14.79M	10.26M	7.12M	11.56M	16.59M	11.20M	5.53M	9.10M	11.20M	7.15M
Accumulated Expenses (Quarter)	13.21M	17.86M	24.30M	17.80M	20.17M	42.15M	53.61M	53.32M	48.08M	53.21M	61.27M	69.31M	7.29M	8.01M	104.08M	0.42M	9.44M	119.64M	11.36M	125.25M
Other Accumulated Expenses (Quarter)											0.47M		0.37M	0.45M	0.42M	2.23M	0.75M	0.84M	0.84M	0.74M
Current Taxes (Quarter)											0.73M		0.01M		0.89M	11.09M	0.44M	0.71M	1.40M	19.63M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	16.14M	20.61M	27.06M	22.94M	22.49M	44.68M	57.59M	56.71M	52.50M	57.81M	76.06M	79.57M	92.32M	105.39M	120.68M	111.65M	113.01M	128.74M	147.15M	132.40M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)	4.25M	4.25M	3.89M	4.13M	3.73M	3.97M	3.56M	3.47M	3.38M	3.28M	3.19M	3.09M	2.99M	2.89M	2.79M	2.68M	2.57M	2.46M	2.35M	2.23M
Other Non-Current Liabilities (Quarter)						14.75M	14.06M	13.39M	12.72M	3.58M	2.98M	2.61M	2.40M	2.79M	0.32M	0.26M	0.31M	0.16M	0.21M	0.28M
Total Non-Current Liabilities (Quarter)			30.96M			48.32M	61.15M	60.18M	55.88M	61.09M	79.25M	82.66M	95.31M	108.28M	123.46M	114.33M	115.58M	131.20M	149.50M	134.63M
Total Liabilities (Quarter)	20.19M	24.59M	30.96M	26.75M	26.22M	63.07M	75.21M	73.57M	68.60M	64.66M	82.23M	85.26M	97.70M	111.07M	123.78M	114.59M	115.89M	131.36M	149.71M	134.91M
Shareholder's Equity
Common Equity (Quarter)	188.94M	198.66M	206.83M	220.22M	241.09M	270.04M	300.42M	333.66M	375.29M	348.55M	387.88M	561.41M	608.65M	660.94M	727.63M	794.28M	856.03M	920.25M	954.27M	1,012.70M
Shareholder's Equity (Quarter)	188.94M	198.66M	206.83M	220.22M	241.09M	270.04M	300.42M	333.66M	375.29M	348.55M	387.88M	561.41M	608.65M	660.94M	727.63M	794.28M	856.03M	920.25M	954.27M	1,012.70M
Liabilities and Shareholders Equity (Quarter)	209.13M	223.25M	237.79M	246.97M	267.31M	333.11M	375.63M	407.23M	443.90M	413.21M	470.11M	646.68M	706.36M	772.01M	851.41M	908.87M	971.91M	1,051.60M	1,103.98M	1,147.61M
Retained Earnings (Quarter)	-0.04M	-0.06M	-0.15M	-0.45M	-0.13M	0.03M	0.02M	0.01M	0.02M	0.01M	0.01M				0.06M	-0.02M	0.03M	446.79M	474.19M	523.35M
Treasury Shares (Quarter)	0.73M	0.95M	-2.21M	-0.40M	-0.60M	-1.00M	1.00M								0.71M				0.75M	0.62M

Research Tools

Catalyst Pharmaceuticals Balance Sheet (2010-2026) | CPRX

Create an account

Sign In

Reset Password